The RSA is an on-line project submission process. Investigators are strongly encouraged to contact the PCGT prior to initiating or completing an RSA. Please contact the PCGT Coordinator here for any questions or to set up a meeting with the PCGT.
Investigators must be conducting gene therapy research at an institution located in the United States to qualify to submit an RSA.
1. Requirements
• The applicant must be working in gene therapy research in a disease area funded by the NIH and on a translational pathway.
2. Submission Process
• Investigators must first complete the first page of the form during the Registration process to access the secure website to submit an RSA.
• Investigators can enter information and save the RSA in stages.
• Each RSA will be assigned a unique identifier at the time the RSA is initiated. Refer to this number in all correspondence or submission of supplemental forms or materials.